Patient Decision Aid for Antidepressant Use in Pregnancy

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
PregnancyDepression
Interventions
BEHAVIORAL

Electronic Patient Decision Aid

"The electronic Patient Decision Aid (PDA) is an interactive website with 3 main sections:~1. Evidence-based information on (a) depression in pregnancy, (b) each treatment option and procedure;~2. (a) Evidence-based information on the risks and benefits of both untreated depression and antidepressant treatment, (b) exercises to help women determine which risks and benefits are most important to them; and~3. A summary section that outlines the information reviewed and which benefits and risks they deemed most important."

BEHAVIORAL

Standard Resource Sheet

"Women allocated to the control intervention will login to the study website and receive a printable PDF containing references to standard published information on antidepressant use in pregnancy. This ensures women have access to accurate information on the benefits and risks of antidepressant medication in pregnancy (even though they will not receive the PDA).~Women who are assigned the control condition AND who are not receiving care from Women's College Hospital Reproductive Life Stages Program will receive waitlisted access to the intervention after data collected at 4 weeks post-randomization."

Trial Locations (1)

M5S 1B2

Women's College Hospital, Toronto

All Listed Sponsors
collaborator

Ontario Ministry of Health and Long Term Care

OTHER_GOV

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Women's College Hospital

OTHER

NCT02308592 - Patient Decision Aid for Antidepressant Use in Pregnancy | Biotech Hunter | Biotech Hunter